1 U.S. lawmaker has disclosed 13 Humacyte, Inc. - trades under the STOCK Act — 7 buys and 6 sells between 2022 and 2024. Congress has been net buyers of HUMA, and their disclosed buys are down 85.0% versus the latest close.
*Notional-weighted price return on lawmakers' disclosed buys of HUMA, marked to the latest close — per-share (share counts aren't disclosed).
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2024-05-03 | Thomas H Tuberville | SELL | $15K–$50K | $4.41 | $0.55 2026-08-13 | +13.9% rt |
| 2024-05-03 | Thomas H Tuberville | SELL | $1K–$15K | $4.41 | $0.55 2026-08-13 | +22.5% rt |
| 2024-05-03 | Thomas H Tuberville | SELL | $15K–$50K | $4.41 | $0.55 2026-08-13 | +22.5% rt |
| 2024-05-03 | Thomas H Tuberville | SELL | $1K–$15K | $4.41 | $0.55 2026-08-13 | +22.5% rt |
| 2024-04-30 | Thomas H Tuberville | SELL | $50K–$100K | $3.92 | $0.55 2026-08-13 | +36.6% rt |
| 2024-03-21 | Thomas H Tuberville | BUY | $15K–$50K | $3.60 | $0.55 2026-08-13 | -84.7% |
| 2024-03-21 | Thomas H Tuberville | BUY | $1K–$15K | $3.60 | $0.55 2026-08-13 | -84.7% |
| 2024-03-21 | Thomas H Tuberville | BUY | $15K–$50K | $3.60 | $0.55 2026-08-13 | -84.7% |
| 2024-03-21 | Thomas H Tuberville | BUY | $1K–$15K | $3.60 | $0.55 2026-08-13 | -84.7% |
| 2024-02-12 | Thomas H Tuberville | BUY | $15K–$50K | $3.87 | $0.55 2026-08-13 | -85.8% |
| 2024-01-19 | Thomas H Tuberville | SELL | $1K–$15K | $2.67 | $0.55 2026-08-13 | -63.3% rt |
| 2023-07-25 | Thomas H Tuberville | BUY | $1K–$15K | $2.87 | $0.55 2026-08-13 | -80.8% |
| 2022-03-30 | Thomas H Tuberville | BUY | $15K–$50K | $7.27 | $0.55 2026-08-13 | -92.4% |
Return: buys marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (stock move after the sale, seller's perspective).
1 member of the U.S. House and Senate has disclosed Humacyte, Inc. - transactions under the STOCK Act — 7 purchases and 6 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
No member of Congress has disclosed a HUMA purchase in the last 90 days. STOCK Act filings lag the trade by up to 45 days, so newer buys may still be pending disclosure.
Notional-weighted, lawmakers' disclosed HUMA buys are down 85.0% versus the latest close of $0.55. Each trade's own return — and realized round-trips on matched sells — is in the Return column.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded HUMA and how it performed.